One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Japan Diagnostic Imaging Market

Japan Diagnostic Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)


Product Code : MDHC00121730
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Canon Medical Systems Corporation
- Carestream Health, Inc.
- Esaote SpA
- Fujifilm Holdings
- GE Healthcare
- Hitachi Medical Corporation
- Hologic, Inc.
- Philips Healthcare
- Shimadzu Corporation
- Siemens Healthcare

[Report Description]

The major factors augmenting the growth of the diagnostic imaging market in Japan include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and the rise in the geriatric population.



According to the Statistics Bureau of Japan, the country is experiencing a “super-aging” society both in rural and urban areas. As per 2016 estimates, 33.0% of the Japanese population was above the age of 60, 25.9% are aged 65 or above, and 12.5% are aged 75 or above. Moreover, the prevalence of chronic diseases is also increasing among the Japanese population, and more so among the geriatric population as they are more prone to diseases. But Japan is a developed country that has a developed healthcare system as well. The healthcare industry in Japan has well adopted new innovations and advancements for diagnosis. These factors have helped this diagnostic imaging market grow in Japan.



However, the cost of diagnosis due to expensive instruments and side effects that follow the diagnostic imaging have been restraining the growth of this market.



Key Market Trends



Oncology Segment is expected to Account for Largest Market Share during the Forecast Period



According to the Annals of Cancer Epidemiology, cancer as a cause of death has been constantly increasing and is the leading cause of death in Japan. Age-standardized incidence rates for males and females in Japan were 303.1 and 224.8 per 100,000, respectively as per the same report.



Diagnostic imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. Tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.



As Japan has a developed healthcare system, these technologies have been implemented into the routine and have been helping the patients and physicians as well. Hence, an increased prevalence of cancer and the implementation of new technologies are expected to help this segment dominate the market.



Competitive Landscape



Japan has been an attractive market for domestic and international players as well. The leading vendors in the market are launching advanced diagnostic imaging equipment. These companies have also been involved in the acquisition of related healthcare companies, in order to improve their product portfolio, geographical presence, and growth. By incorporating the acquired technologies, the companies are driving product innovation.



Additional Benefits:



  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing geriatric poulation
4.2.2 Increased adoption of diagnostic imaging by the medical industry
4.2.3 Technological advances and rapid innovation
4.2.4 Increased incidence of chronic diseases
4.3 Market Restraints
4.3.1 Expensive procedures and equipment
4.3.2 Side effects of diagnostic imaging procedures
4.4 Porter s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Modality
5.1.1 MRI
5.1.2 Computed Tomography��
5.1.3 Ultrasound
5.1.4 X-Ray
5.1.5 Nuclear Imaging
5.1.6 Fluoroscopy
5.1.7 Mammography
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Gastroenterology
5.2.6 Gynecology
5.2.7 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostic Centers
5.3.3 Others

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health, Inc.
6.1.3 Esaote SpA
6.1.4 Fujifilm Holdings
6.1.5 GE Healthcare
6.1.6 Hitachi Medical Corporation
6.1.7 Hologic, Inc.
6.1.8 Philips Healthcare
6.1.9 Shimadzu Corporation
6.1.10 Siemens Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+